Screener
ANI Pharmaceuticals ANIP Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's net income?
- ANI Pharmaceuticals (ANIP) reported net income of $24.71M in Q2 2026.
- How has ANI Pharmaceuticals's net income changed year-over-year?
- ANI Pharmaceuticals's net income increased by 189.1% year-over-year, from $8.55M to $24.71M.
- What is the long-term trend for ANI Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's net income has grown at a 16.4% compound annual growth rate (CAGR), from -$42.6M to $78.34M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about ANI Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude